The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Jens Lagerstedt

Associate professor

Default user image.

APOLIPOPROTEIN A-I DERIVED PEPTIDES FOR TREATMENT OF HYPERGLYCAEMIA

Other contributions

  • Jens Lagerstedt
  • Karin Stenkula

Summary, in English

The present invention relates to peptides derived from
apolipoprotein A-I (apoA-I) and their use for treatment or prevention of
diseases and disorders associated with hyper-glycaemia.

Department/s

  • Medical Protein Science
  • Glucose Transport and Protein Trafficking
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year

2014-01-27

Language

English

Document type

Patent

Topic

  • Physiology

Keywords

  • apolipoprotein A-i
  • Hyperglycaemia

Status

Published

Research group

  • Medical Protein Science
  • Glucose Transport and Protein Trafficking

ISBN/ISSN/Other

  • https://www.lens.org/lens/patent/019-094-625-110-905